Medicinal application of long synthetic peptide technology.
Détails
ID Serval
serval:BIB_D8A7EF59A754
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Medicinal application of long synthetic peptide technology.
Périodique
Expert opinion on biological therapy
ISSN
1744-7682[electronic]
Statut éditorial
Publié
Date de publication
2004
Volume
4
Numéro
10
Pages
1629-39
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review - Publication Status: ppublish
Résumé
This review covers the latest developments of long synthetic peptide technology for the rapid identification and development of malaria vaccine candidates and immunological modulators. A brief description of the two most common solid-phase synthetic procedures, together with the latest advances in optimisation of peptide chain assembly and analytical instrumentation, is given, with special attention to non-specialists. Several examples of vaccine candidates developed in the authors' or their collaborators' laboratories are also provided.
Mots-clé
Animals, Antigens, Protozoan, B-Lymphocytes, Bee Venoms, Chemistry, Organic, Clinical Trials as Topic, Epitopes, Humans, Hypersensitivity, Immediate, Malaria Vaccines, Mice, Mice, Inbred BALB C, Peptides, Phospholipases A, Plasmodium falciparum, Plasmodium vivax, Protozoan Proteins, T-Lymphocyte Subsets, Vaccines, Subunit, Vaccines, Synthetic
Pubmed
Web of science
Création de la notice
24/01/2008 15:55
Dernière modification de la notice
20/08/2019 16:58
Données d'usage
